Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Actavis, Bioton sign JV for development and sale of insulin products; terminated

Executive Summary

Swiss generics company Actavis Group and Polish biopharma Bioton SA have created a joint venture to develop and register insulins and their analogues for diabetes.
Deal Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Co-Marketing
    • R+D and Marketing-Licensing
    • Includes Royalty or Profit Split Information
    • Joint Venture

Related Companies

Advertisement
UsernamePublicRestriction

Register